Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mensa

Showing results (321-330 of 791) with videos related to

Pageof 80
Sort By:
The Journal of Antimicrobial Chemotherapy|February 28, 2002
Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolatesJordi Vila, Anna Ribera, Francesc Marco, et al.
International Journal of Clinical Pharmacy|February 21, 2020
Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care levelMarina Rovira-Illamola, Neus Pagès-Puigdemont, Josep Miquel Sotoca-Momblona, et al.
The International Journal of Artificial Organs|October 16, 2012
Long-term results of acute prosthetic joint infection treated with debridement and prosthesis retention: a case-control studyLluís Font-Vizcarra, Sebastián García, Guillem Bori, et al.
Preventing Chronic Disease|December 8, 2017
Early Results of States' Efforts to Support, Scale, and Sustain the National Diabetes Prevention ProgramYvonne Mensa-Wilmot, Shelly-Ann Bowen, Stephanie Rutledge, et al.
Medicina Clinica|November 14, 1992
[Rapid method for identifying Escherichia coli and species of the Proteeae tribe in urine]J Vila, A Gené, C García, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniaeJ M Sierra, J G Cabeza, M Ruiz Chaler, et al.
Thorax|February 5, 2008
Markers of treatment failure in hospitalised community acquired pneumoniaR Menéndez, M Cavalcanti, S Reyes, et al.
Tetrahedron|May 9, 2020
Design, Synthesis, and Evaluation of Novel Anti-Trypanosomal CompoundsLance T Lepovitz, Alan R Meis, Sarah M Thomas, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2006
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemiaJosé A Martínez, Josefa Aguilar, Manel Almela, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 2, 2007
Epidemiology and outcome of primary community-acquired bacteremia in adult patientsM Ortega, M Almela, J A Martinez, et al.
Pageof 80

Showing results (321-330 of 791) with videos related to

Sort By:
Pageof 80
The Journal of Antimicrobial Chemotherapy|February 28, 2002
Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolatesJordi Vila, Anna Ribera, Francesc Marco, et al.
International Journal of Clinical Pharmacy|February 21, 2020
Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care levelMarina Rovira-Illamola, Neus Pagès-Puigdemont, Josep Miquel Sotoca-Momblona, et al.
The International Journal of Artificial Organs|October 16, 2012
Long-term results of acute prosthetic joint infection treated with debridement and prosthesis retention: a case-control studyLluís Font-Vizcarra, Sebastián García, Guillem Bori, et al.
Preventing Chronic Disease|December 8, 2017
Early Results of States' Efforts to Support, Scale, and Sustain the National Diabetes Prevention ProgramYvonne Mensa-Wilmot, Shelly-Ann Bowen, Stephanie Rutledge, et al.
Medicina Clinica|November 14, 1992
[Rapid method for identifying Escherichia coli and species of the Proteeae tribe in urine]J Vila, A Gené, C García, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniaeJ M Sierra, J G Cabeza, M Ruiz Chaler, et al.
Thorax|February 5, 2008
Markers of treatment failure in hospitalised community acquired pneumoniaR Menéndez, M Cavalcanti, S Reyes, et al.
Tetrahedron|May 9, 2020
Design, Synthesis, and Evaluation of Novel Anti-Trypanosomal CompoundsLance T Lepovitz, Alan R Meis, Sarah M Thomas, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2006
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemiaJosé A Martínez, Josefa Aguilar, Manel Almela, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 2, 2007
Epidemiology and outcome of primary community-acquired bacteremia in adult patientsM Ortega, M Almela, J A Martinez, et al.
Pageof 80